Filings buzz in pharma: 95% increase in digitalization mentions in Q1 of 2022
Novartis referred to digitalization the most between April 2021 and March 2022.
By
Novartis referred to digitalization the most between April 2021 and March 2022.
ByWe've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
ByIQVIA referred to AI the most in 2021, with 26 AI-related sentences in the company's filings.
ByIQVIA was the company which referred to artificial intelligence the most during 2021.
ByWe've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
ByWe've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
ByWe've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
ByMentions of industrial automation fell 39% between the third and fourth quarters of 2021.
ByThank you for subscribing to Clinical Trials Arena